Global Exosome Diagnostics and Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Exosome Diagnostics and Therapeutics Market Size was estimated at USD 137.31 million in 2023 and is projected to reach USD 827.53 million by 2029, exhibiting a CAGR of 34.90% during the forecast period.
This report provides a deep insight into the global Exosome Diagnostics and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Exosome Diagnostics and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Exosome Diagnostics and Therapeutics market in any manner.
Global Exosome Diagnostics and Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Market Segmentation (by Type)
Instrument
Reagent
Software
Market Segmentation (by Application)
Diagnostic
Therapeutic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Exosome Diagnostics and Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Exosome Diagnostics and Therapeutics Market Size was estimated at USD 137.31 million in 2023 and is projected to reach USD 827.53 million by 2029, exhibiting a CAGR of 34.90% during the forecast period.
This report provides a deep insight into the global Exosome Diagnostics and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Exosome Diagnostics and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Exosome Diagnostics and Therapeutics market in any manner.
Global Exosome Diagnostics and Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Market Segmentation (by Type)
Instrument
Reagent
Software
Market Segmentation (by Application)
Diagnostic
Therapeutic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Exosome Diagnostics and Therapeutics Market
- Overview of the regional outlook of the Exosome Diagnostics and Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Exosome Diagnostics and Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Exosome Diagnostics and Therapeutics
1.2 Key Market Segments
1.2.1 Exosome Diagnostics and Therapeutics Segment by Type
1.2.2 Exosome Diagnostics and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Exosome Diagnostics and Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Exosome Diagnostics and Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Exosome Diagnostics and Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Exosome Diagnostics and Therapeutics Sales Sites, Area Served, Product Type
3.6 Exosome Diagnostics and Therapeutics Market Competitive Situation and Trends
3.6.1 Exosome Diagnostics and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Exosome Diagnostics and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 EXOSOME DIAGNOSTICS AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Exosome Diagnostics and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Exosome Diagnostics and Therapeutics Price by Type (2019-2024)
7 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Exosome Diagnostics and Therapeutics Market Sales by Application (2019-2024)
7.3 Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2019-2024)
8 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Exosome Diagnostics and Therapeutics Sales by Region
8.1.1 Global Exosome Diagnostics and Therapeutics Sales by Region
8.1.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Exosome Diagnostics and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Exosome Diagnostics and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Exosome Diagnostics and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Aethlon Medical(US)
9.1.1 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Basic Information
9.1.2 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
9.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Market Performance
9.1.4 Aethlon Medical(US) Business Overview
9.1.5 Aethlon Medical(US) Exosome Diagnostics and Therapeutics SWOT Analysis
9.1.6 Aethlon Medical(US) Recent Developments
9.2 Exosome Diagnostics(US)
9.2.1 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Basic Information
9.2.2 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
9.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Market Performance
9.2.4 Exosome Diagnostics(US) Business Overview
9.2.5 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics SWOT Analysis
9.2.6 Exosome Diagnostics(US) Recent Developments
9.3 NanoSomix Inc.(US)
9.3.1 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Basic Information
9.3.2 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
9.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Market Performance
9.3.4 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics SWOT Analysis
9.3.5 NanoSomix Inc.(US) Business Overview
9.3.6 NanoSomix Inc.(US) Recent Developments
9.4 Thermo Fisher Scientific (US)
9.4.1 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Basic Information
9.4.2 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
9.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Market Performance
9.4.4 Thermo Fisher Scientific (US) Business Overview
9.4.5 Thermo Fisher Scientific (US) Recent Developments
9.5 Malvern Instruments (UK)
9.5.1 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Basic Information
9.5.2 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
9.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Market Performance
9.5.4 Malvern Instruments (UK) Business Overview
9.5.5 Malvern Instruments (UK) Recent Developments
9.6 System Biosciences(US)
9.6.1 System Biosciences(US) Exosome Diagnostics and Therapeutics Basic Information
9.6.2 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
9.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Market Performance
9.6.4 System Biosciences(US) Business Overview
9.6.5 System Biosciences(US) Recent Developments
9.7 NX Pharmagen (US)
9.7.1 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Basic Information
9.7.2 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
9.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Market Performance
9.7.4 NX Pharmagen (US) Business Overview
9.7.5 NX Pharmagen (US) Recent Developments
9.8 Sistemic Inc(UK)
9.8.1 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Basic Information
9.8.2 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
9.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Market Performance
9.8.4 Sistemic Inc(UK) Business Overview
9.8.5 Sistemic Inc(UK) Recent Developments
9.9 Capricor Therapeutics (US)
9.9.1 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Basic Information
9.9.2 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
9.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Market Performance
9.9.4 Capricor Therapeutics (US) Business Overview
9.9.5 Capricor Therapeutics (US) Recent Developments
9.10 Exiqon A/S (Denmark)
9.10.1 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Basic Information
9.10.2 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
9.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Market Performance
9.10.4 Exiqon A/S (Denmark) Business Overview
9.10.5 Exiqon A/S (Denmark) Recent Developments
10 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Exosome Diagnostics and Therapeutics Market Size Forecast
10.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region
10.2.4 South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Exosome Diagnostics and Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Exosome Diagnostics and Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Exosome Diagnostics and Therapeutics by Type (2025-2030)
11.1.2 Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Exosome Diagnostics and Therapeutics by Type (2025-2030)
11.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Exosome Diagnostics and Therapeutics
1.2 Key Market Segments
1.2.1 Exosome Diagnostics and Therapeutics Segment by Type
1.2.2 Exosome Diagnostics and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Exosome Diagnostics and Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Exosome Diagnostics and Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Exosome Diagnostics and Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Exosome Diagnostics and Therapeutics Sales Sites, Area Served, Product Type
3.6 Exosome Diagnostics and Therapeutics Market Competitive Situation and Trends
3.6.1 Exosome Diagnostics and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Exosome Diagnostics and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 EXOSOME DIAGNOSTICS AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Exosome Diagnostics and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Exosome Diagnostics and Therapeutics Price by Type (2019-2024)
7 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Exosome Diagnostics and Therapeutics Market Sales by Application (2019-2024)
7.3 Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2019-2024)
8 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Exosome Diagnostics and Therapeutics Sales by Region
8.1.1 Global Exosome Diagnostics and Therapeutics Sales by Region
8.1.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Exosome Diagnostics and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Exosome Diagnostics and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Exosome Diagnostics and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Aethlon Medical(US)
9.1.1 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Basic Information
9.1.2 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
9.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Market Performance
9.1.4 Aethlon Medical(US) Business Overview
9.1.5 Aethlon Medical(US) Exosome Diagnostics and Therapeutics SWOT Analysis
9.1.6 Aethlon Medical(US) Recent Developments
9.2 Exosome Diagnostics(US)
9.2.1 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Basic Information
9.2.2 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
9.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Market Performance
9.2.4 Exosome Diagnostics(US) Business Overview
9.2.5 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics SWOT Analysis
9.2.6 Exosome Diagnostics(US) Recent Developments
9.3 NanoSomix Inc.(US)
9.3.1 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Basic Information
9.3.2 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
9.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Market Performance
9.3.4 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics SWOT Analysis
9.3.5 NanoSomix Inc.(US) Business Overview
9.3.6 NanoSomix Inc.(US) Recent Developments
9.4 Thermo Fisher Scientific (US)
9.4.1 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Basic Information
9.4.2 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
9.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Market Performance
9.4.4 Thermo Fisher Scientific (US) Business Overview
9.4.5 Thermo Fisher Scientific (US) Recent Developments
9.5 Malvern Instruments (UK)
9.5.1 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Basic Information
9.5.2 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
9.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Market Performance
9.5.4 Malvern Instruments (UK) Business Overview
9.5.5 Malvern Instruments (UK) Recent Developments
9.6 System Biosciences(US)
9.6.1 System Biosciences(US) Exosome Diagnostics and Therapeutics Basic Information
9.6.2 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
9.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Market Performance
9.6.4 System Biosciences(US) Business Overview
9.6.5 System Biosciences(US) Recent Developments
9.7 NX Pharmagen (US)
9.7.1 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Basic Information
9.7.2 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
9.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Market Performance
9.7.4 NX Pharmagen (US) Business Overview
9.7.5 NX Pharmagen (US) Recent Developments
9.8 Sistemic Inc(UK)
9.8.1 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Basic Information
9.8.2 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
9.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Market Performance
9.8.4 Sistemic Inc(UK) Business Overview
9.8.5 Sistemic Inc(UK) Recent Developments
9.9 Capricor Therapeutics (US)
9.9.1 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Basic Information
9.9.2 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
9.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Market Performance
9.9.4 Capricor Therapeutics (US) Business Overview
9.9.5 Capricor Therapeutics (US) Recent Developments
9.10 Exiqon A/S (Denmark)
9.10.1 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Basic Information
9.10.2 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
9.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Market Performance
9.10.4 Exiqon A/S (Denmark) Business Overview
9.10.5 Exiqon A/S (Denmark) Recent Developments
10 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Exosome Diagnostics and Therapeutics Market Size Forecast
10.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region
10.2.4 South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Exosome Diagnostics and Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Exosome Diagnostics and Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Exosome Diagnostics and Therapeutics by Type (2025-2030)
11.1.2 Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Exosome Diagnostics and Therapeutics by Type (2025-2030)
11.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Exosome Diagnostics and Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Exosome Diagnostics and Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Exosome Diagnostics and Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2022)
Table 10. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Exosome Diagnostics and Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Exosome Diagnostics and Therapeutics Product Type
Table 13. Global Exosome Diagnostics and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Exosome Diagnostics and Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Exosome Diagnostics and Therapeutics Market Challenges
Table 22. Global Exosome Diagnostics and Therapeutics Sales by Type (K Units)
Table 23. Global Exosome Diagnostics and Therapeutics Market Size by Type (M USD)
Table 24. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Exosome Diagnostics and Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Exosome Diagnostics and Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Application
Table 30. Global Exosome Diagnostics and Therapeutics Market Size by Application
Table 31. Global Exosome Diagnostics and Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Exosome Diagnostics and Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Exosome Diagnostics and Therapeutics Market Share by Application (2019-2024)
Table 35. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Exosome Diagnostics and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Exosome Diagnostics and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Exosome Diagnostics and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Exosome Diagnostics and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Basic Information
Table 44. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
Table 45. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Aethlon Medical(US) Business Overview
Table 47. Aethlon Medical(US) Exosome Diagnostics and Therapeutics SWOT Analysis
Table 48. Aethlon Medical(US) Recent Developments
Table 49. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Basic Information
Table 50. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
Table 51. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Exosome Diagnostics(US) Business Overview
Table 53. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics SWOT Analysis
Table 54. Exosome Diagnostics(US) Recent Developments
Table 55. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Basic Information
Table 56. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
Table 57. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics SWOT Analysis
Table 59. NanoSomix Inc.(US) Business Overview
Table 60. NanoSomix Inc.(US) Recent Developments
Table 61. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Basic Information
Table 62. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
Table 63. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Thermo Fisher Scientific (US) Business Overview
Table 65. Thermo Fisher Scientific (US) Recent Developments
Table 66. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Basic Information
Table 67. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
Table 68. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Malvern Instruments (UK) Business Overview
Table 70. Malvern Instruments (UK) Recent Developments
Table 71. System Biosciences(US) Exosome Diagnostics and Therapeutics Basic Information
Table 72. System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
Table 73. System Biosciences(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. System Biosciences(US) Business Overview
Table 75. System Biosciences(US) Recent Developments
Table 76. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Basic Information
Table 77. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
Table 78. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. NX Pharmagen (US) Business Overview
Table 80. NX Pharmagen (US) Recent Developments
Table 81. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Basic Information
Table 82. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
Table 83. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sistemic Inc(UK) Business Overview
Table 85. Sistemic Inc(UK) Recent Developments
Table 86. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Basic Information
Table 87. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
Table 88. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Capricor Therapeutics (US) Business Overview
Table 90. Capricor Therapeutics (US) Recent Developments
Table 91. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Basic Information
Table 92. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
Table 93. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Exiqon A/S (Denmark) Business Overview
Table 95. Exiqon A/S (Denmark) Recent Developments
Table 96. Global Exosome Diagnostics and Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Exosome Diagnostics and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Exosome Diagnostics and Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Exosome Diagnostics and Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Exosome Diagnostics and Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Exosome Diagnostics and Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Exosome Diagnostics and Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Exosome Diagnostics and Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Exosome Diagnostics and Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2022)
Table 10. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Exosome Diagnostics and Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Exosome Diagnostics and Therapeutics Product Type
Table 13. Global Exosome Diagnostics and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Exosome Diagnostics and Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Exosome Diagnostics and Therapeutics Market Challenges
Table 22. Global Exosome Diagnostics and Therapeutics Sales by Type (K Units)
Table 23. Global Exosome Diagnostics and Therapeutics Market Size by Type (M USD)
Table 24. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Exosome Diagnostics and Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Exosome Diagnostics and Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Application
Table 30. Global Exosome Diagnostics and Therapeutics Market Size by Application
Table 31. Global Exosome Diagnostics and Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Exosome Diagnostics and Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Exosome Diagnostics and Therapeutics Market Share by Application (2019-2024)
Table 35. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Exosome Diagnostics and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Exosome Diagnostics and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Exosome Diagnostics and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Exosome Diagnostics and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Basic Information
Table 44. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
Table 45. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Aethlon Medical(US) Business Overview
Table 47. Aethlon Medical(US) Exosome Diagnostics and Therapeutics SWOT Analysis
Table 48. Aethlon Medical(US) Recent Developments
Table 49. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Basic Information
Table 50. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
Table 51. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Exosome Diagnostics(US) Business Overview
Table 53. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics SWOT Analysis
Table 54. Exosome Diagnostics(US) Recent Developments
Table 55. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Basic Information
Table 56. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
Table 57. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics SWOT Analysis
Table 59. NanoSomix Inc.(US) Business Overview
Table 60. NanoSomix Inc.(US) Recent Developments
Table 61. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Basic Information
Table 62. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
Table 63. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Thermo Fisher Scientific (US) Business Overview
Table 65. Thermo Fisher Scientific (US) Recent Developments
Table 66. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Basic Information
Table 67. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
Table 68. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Malvern Instruments (UK) Business Overview
Table 70. Malvern Instruments (UK) Recent Developments
Table 71. System Biosciences(US) Exosome Diagnostics and Therapeutics Basic Information
Table 72. System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
Table 73. System Biosciences(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. System Biosciences(US) Business Overview
Table 75. System Biosciences(US) Recent Developments
Table 76. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Basic Information
Table 77. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
Table 78. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. NX Pharmagen (US) Business Overview
Table 80. NX Pharmagen (US) Recent Developments
Table 81. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Basic Information
Table 82. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
Table 83. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sistemic Inc(UK) Business Overview
Table 85. Sistemic Inc(UK) Recent Developments
Table 86. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Basic Information
Table 87. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
Table 88. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Capricor Therapeutics (US) Business Overview
Table 90. Capricor Therapeutics (US) Recent Developments
Table 91. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Basic Information
Table 92. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
Table 93. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Exiqon A/S (Denmark) Business Overview
Table 95. Exiqon A/S (Denmark) Recent Developments
Table 96. Global Exosome Diagnostics and Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Exosome Diagnostics and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Exosome Diagnostics and Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Exosome Diagnostics and Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Exosome Diagnostics and Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Exosome Diagnostics and Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Exosome Diagnostics and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Exosome Diagnostics and Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Exosome Diagnostics and Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Exosome Diagnostics and Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Exosome Diagnostics and Therapeutics Market Size by Country (M USD)
Figure 11. Exosome Diagnostics and Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Exosome Diagnostics and Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Exosome Diagnostics and Therapeutics Market Share by Type
Figure 18. Sales Market Share of Exosome Diagnostics and Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Exosome Diagnostics and Therapeutics by Type in 2023
Figure 20. Market Size Share of Exosome Diagnostics and Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Exosome Diagnostics and Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Exosome Diagnostics and Therapeutics Market Share by Application
Figure 24. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Exosome Diagnostics and Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Exosome Diagnostics and Therapeutics Market Share by Application in 2023
Figure 28. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Exosome Diagnostics and Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Exosome Diagnostics and Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2023
Figure 44. China Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Exosome Diagnostics and Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Exosome Diagnostics and Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Exosome Diagnostics and Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Exosome Diagnostics and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Exosome Diagnostics and Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Exosome Diagnostics and Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Exosome Diagnostics and Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Exosome Diagnostics and Therapeutics Market Size by Country (M USD)
Figure 11. Exosome Diagnostics and Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Exosome Diagnostics and Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Exosome Diagnostics and Therapeutics Market Share by Type
Figure 18. Sales Market Share of Exosome Diagnostics and Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Exosome Diagnostics and Therapeutics by Type in 2023
Figure 20. Market Size Share of Exosome Diagnostics and Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Exosome Diagnostics and Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Exosome Diagnostics and Therapeutics Market Share by Application
Figure 24. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Exosome Diagnostics and Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Exosome Diagnostics and Therapeutics Market Share by Application in 2023
Figure 28. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Exosome Diagnostics and Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Exosome Diagnostics and Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2023
Figure 44. China Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Exosome Diagnostics and Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Exosome Diagnostics and Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Exosome Diagnostics and Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Application (2025-2030)
